AngioGenex, Inc. SEC EDGAR Filings (CIK 0001085596)

SEC EDGAR filings, ownership reports, and insider transactions for AngioGenex, Inc..

Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
425 Madison Avenue, Suite 902, New York, NY, 10017
State of incorporation
NV
Fiscal year end
31 December
Former names
ECLIC INC/NV (to 05 Jan 2006)
⭐ Add to watchlist ⭐
Get insider transactions for this issuer
AngioGenex, Inc. has filed 161 SEC EDGAR filings since 24 May 1999

Latest Filings

Recent SEC filings for AngioGenex, Inc. including REVOKED, 5, D and more.

Form type Document Filing Description Filing date Reporting date File number(s)
REVOKED Open REVOKED document View SEC filing for REVOKED 10 Mar 2023 000-26181
5 Open 5 document View SEC filing for 5 17 Feb 2022 31 Dec 2021
5 Open 5 document View SEC filing for 5 16 Feb 2022 31 Dec 2021
5 Open 5 document View SEC filing for 5 16 Feb 2022 31 Dec 2021
5 Open 5 document View SEC filing for 5 15 Feb 2022 31 Dec 2021
D Open D document View SEC filing for D 17 Dec 2021 021-425689
8-K Open 8-K document View SEC filing for 8-K AGGX 8-K 12/15/21 16 Dec 2021 09 Dec 2021 000-26181
3 Open 3 document View SEC filing for 3 13 Jul 2020 30 Jun 2020
8-K Open 8-K document View SEC filing for 8-K AGGX 8-K 07/10/20 13 Jul 2020 30 Jun 2020 000-26181
8-K Open 8-K document View SEC filing for 8-K AGGX 8-K 02/11/20 11 Feb 2020 28 Jan 2020 000-26181
8-K Open 8-K document View SEC filing for 8-K AGGX 8-K 09/13/19 13 Sep 2019 12 Sep 2019 000-26181
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q AGGX 10-Q 06/30/19 14 Aug 2019 30 Jun 2019 000-26181
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q AGGX 10-Q 03/31/19 20 May 2019 31 Mar 2019 000-26181
NT 10-Q Open NT 10-Q document View SEC filing for NT 10-Q AGGX NT10-Q 03/31/19 15 May 2019 31 Mar 2019 000-26181
DEF 14A Open DEF 14A document View SEC filing for DEF 14A AGGX DEF14A 04/01/19 01 Apr 2019 01 Apr 2019 000-26181
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K AGGX 10-K 12/31/18 28 Mar 2019 31 Dec 2018 000-26181
4 Open 4 document View SEC filing for 4 04 Feb 2019 15 Jan 2019
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q AGGX 10-Q 09/30/18 13 Nov 2018 30 Sep 2018 000-26181
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q AGGX 10-Q 06/30/18 14 Aug 2018 30 Jun 2018 000-26181
DEF 14A Open DEF 14A document View SEC filing for DEF 14A AGGX DEF 14A 07/06/18 06 Jul 2018 06 Jul 2018 000-26181
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q AGGX 10-Q 03/31/18 14 May 2018 31 Mar 2018 000-26181
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K AGGX 10-K 12/31/17 02 Apr 2018 31 Dec 2017 000-26181
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 23 Jan 2018 30 Nov 2017
8-K Open 8-K document View SEC filing for 8-K AGGX 8-K 12/05/17 05 Dec 2017 28 Nov 2017 000-26181
DEF 14A Open DEF 14A document View SEC filing for DEF 14A AGGX DEF14A 11/30/17 01 Dec 2017 30 Nov 2007 000-26181
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q AGGX 10-Q 09/30/17 14 Nov 2017 30 Sep 2017 000-26181
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 11 Oct 2017
CORRESP Open CORRESP document View SEC filing for CORRESP 29 Sep 2017
10-12G/A Open 10-12G/A document View SEC filing for 10-12G/A AGGX FORM10-12G/A2 09/29/17 RED 29 Sep 2017 000-26181
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 26 Sep 2017
CORRESP Open CORRESP document View SEC filing for CORRESP 19 Sep 2017
10-12G/A Open 10-12G/A document View SEC filing for 10-12G/A AGGX FORM 10-12G/A1 09/19/17 19 Sep 2017 000-26181
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 05 Sep 2017
10-12G Open 10-12G document View SEC filing for 10-12G AGGX FORM 10-12G 08/22/17 22 Aug 2017 000-26181
CORRESP Open CORRESP document View SEC filing for CORRESP 22 Aug 2017
RW Open RW document View SEC filing for RW AGGX RW 08/22/17 22 Aug 2017 000-26181
CORRESP Open CORRESP document View SEC filing for CORRESP 14 Aug 2017
CORRESP Open CORRESP document View SEC filing for CORRESP 08 Aug 2017
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 25 Jul 2017
10-12G Open 10-12G document View SEC filing for 10-12G AGGX FORM 10-12G 06/27/17 28 Jun 2017 000-26181
8-K Open 8-K document View SEC filing for 8-K AGGX 8-K 04/10/17 10 Apr 2017 05 Apr 2017 000-26181
15-12G Open 15-12G document View SEC filing for 15-12G ANGIOGENEX, INC. FORM 15 12 G 04/13/10 13 Apr 2010 000-26181
NT 10-K Open NT 10-K document View SEC filing for NT 10-K AGGX NT 10-K 012-31-09 31 Mar 2010 31 Dec 2009 000-26181
5 Open 5 document View SEC filing for 5 PRIMARY DOCUMENT 08 Jan 2010 31 Dec 2009
5 Open 5 document View SEC filing for 5 PRIMARY DOCUMENT 08 Jan 2010 31 Dec 2009
5 Open 5 document View SEC filing for 5 PRIMARY DOCUMENT 08 Jan 2010 31 Dec 2009
5 Open 5 document View SEC filing for 5 PRIMARY DOCUMENT 08 Jan 2010 31 Dec 2009

About this filer

AngioGenex, Inc. files with the SEC under CIK 0001085596. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages